Postoperative Radioiodine Can Be Avoided in Patients with Low-Risk Differentiated Thyroid Cancer By Ogkologos - August 12, 2025 544 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the IoN study Source RELATED ARTICLESMORE FROM AUTHOR Antitumour Activity of Rezatapopt Provides Proof of Concept for p53 Reactivation in Patients with TP53 Y220C-mutated Solid Tumours Rare Disease Day 2026: Advancing equity for people living with rare cancers in Europe EMA Recommends Extension of Therapeutic Indications for Ponatinib MOST POPULAR FDA Approves Capivasertib with Fulvestrant for Breast Cancer November 23, 2023 Neoadjuvant Nivolumab/Relatlimab Induces High Rates of Pathologic Responses in Patients with... November 22, 2024 Antibody Drug Ejects Problematic Proteins from Cancer Cells December 13, 2023 Scientists developing urine and blood tests to detect brain tumours July 23, 2021 Load more HOT NEWS Honoring Other’s Wishes Five Questions with…Jennifer. Abiraterone Acetate Plus Prednisone and LHRH Analogue is Active and Safe... Pharmacokinetically Guided Dose Optimisation of Oral Targeted Therapies Reduces the Proportion...
